Sealed Air Sells to CD&R for $10.3 Billion
Sealed Air Corporation agrees to $10.3 billion buyout by CD&R at $42.15 per share. Deal expected to close mid-2026.
Already have an account? Sign in.
Sealed Air Corporation agrees to $10.3 billion buyout by CD&R at $42.15 per share. Deal expected to close mid-2026.
Atara stock jumps 52% after FDA signals its cancer therapy may get approved, boosting hope for patients and investors.
Oppenheimer backs Aprea with $5 target. Its cancer drug shows early promise, and low valuation offers big upside potential.
Angelini is set to buy US-based Catalyst for $31.50 per share in a state-backed deal, expanding into rare neurological diseases and entering the US market.